Facebook Users

Will BIQLF go up?

BIQLF Bioquell PLC featured news, full reports, and detailed charts

Bioquell PLC (BIQLF/BIQLF.PK) Wrap Up:

BIOQUELL plc, through its subsidiaries, engages in the design, manufacture, and supply of bio-decontamination and containment equipment, and related products and services to the healthcare, life sciences, and defense industries in the United Kingdom and internationally. It provides room bio-decontamination service; hydrogen peroxide vapor bio-decontamination equipment; laboratory filtration and containment equipment; and chemical, biological, radiological, and nuclear filtration equipment, as well as after-sales service and support. The company also provides testing, regulatory, and compliance services, including electromagnetic compatibility testing, environmental testing and finite element analysis, and specialist telecoms testing to a range of companies in the aerospace, telecom, and defense industries. BIOQUELL is based in Andover, the United Kingdom.
www.bioquellplc.com
312 Employees

Bioquell PLC (BIQLF:Pink OTC Markets Inc)

LAST $2.58 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of October 30, 2009 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Bioquell PLC (BIQLF)

OPEN
--
PREVIOUS CLOSE
$2.58
DAY HIGH
--
DAY LOW
--
52 WEEK HIGH
10/22/09 - $2.75
52 WEEK LOW
12/22/08 - $1.45
MARKET CAP
107.3M
AVERAGE VOLUME 3 mo
0.0
DILUTED EPS TTM
--
SHARES OUTSTANDING
41.6M
BIQLF Does Not Pay Dividends
P/E TTM
NM
K = Thousands  M = Millions  B = Billions

BIQLF Top Compensated Officers

Mr. Nicholas M. T. Adams
Chief Executive Officer and Executive Directo...
Total Annual Compensation: £350.0K
Mr. B. Mark Bodeker CA
Chief Operating Officer, Finance Director and...
Total Annual Compensation: £303.0K

Executives, Board Directors

Compensation as of Fiscal Year 2008.

Key developments for Bioquell PLC (BIQLF)

Bioquell plc Announces Board Changes

Bioquell plc announced that at its annual meeting held on May 28, 2009, Nigel Keen replaced John Salkeld, who is retiring from the board, as chairman of the company.

Bioquell plc Reports Consolidated Earnings Results for the Year Ended December 31, 2008; Recommends Final Dividend Payable on July 3, 2009 ; Announces Board Changes

Bioquell plc reported consolidated earnings results for the year ended December 31, 2008. For the year, the company reported revenues were £34.4 million compared to revenue of £34.1 million for the previous year. Profit before tax was £5.00 million, increased 20%, compared to pre tax profit of £4.17 million for the previous year. Profit was £3.72 million or 8.3 pence per diluted share compared to profit of £3.65 million or 8.2 pence per diluted share for the previous year. For the year, the company reported operating profit of £5.2 million compared to the £4.2 million for the previous year. For the year, the company reported net cash used in operating activities of £5.8 million compared to the £2.39 million for the previous year. The Board is recommending the payment of a final dividend of 2.2 pence per ordinary share, which represents a 10% increase on the prior year. The final dividend will be payable on July 3, 2009 to shareholders on the register on June 12, 2009. The company reported that after 18 years on the Board, John Salkeld retires as Chairman of the company at the annual general meeting to be held on May 28, 2009. Nigel Keen, currently a non-executive director, is to succeed Mr. Salkeld as Chairman. Tony Bourne, who is currently Chief Executive of the British Medical Association, joined the Board as a non-executive director.

Bioquell plc, Annual General Meeting, May 28, 2009

Bioquell plc, Annual General Meeting, May 28, 2009 Agenda: To approve statutory accounts for the year ended December 31, 2008.

otc, otcbb, pinksheet, BIQLF, ob Bioquell PLC

BIQLF Competitors

Company Last Change
Ecolab Inc $45.29 USD 0.00
Getinge kr135.10 SEK +0.90
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation BIQLF Industry Range
Price/Earnings 100.0x
Price/Sales 140.5x
Price/Book 244.9x
Price/Cash Flow 1,319.7x
TEV/Sales 139.1x

BIQLF

 | 

BIQLF transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent News About Bioquell PLC

Would you like to leave a comment about Bioquell PLC BIQLF/BIQLF.PK

Besides Bioquell PLC there is more great information available at Realpennies.com